PolyPeptide Group Peptide Synthesis and GMP Manufacturing

Pepitides and peptide related compounds

The PolyPeptide Group manufactures peptides and peptide related compounds for the pharmaceutical industry.

Pharmaceutical peptide manufacturing from development to commercialisation

With its capacity for commercial current good manufacturing practice (cGMP) manufacturing and capabilities for small scale non-GMP custom peptides, the PolyPeptide Group can meet the requirements of its clients at all stages of pharmaceutical peptide development from basic research to commercialisation.

The group has six GMP facilities located across three continents including Denmark, France, India, Sweden and the US.

GMP grade peptides can be manufactured at all facilities, in quantities ranging from grams to tens of kilograms.

The flexibility of the designated production site benefits clients, depending on the location of their clinical trials and regulatory filings.

Peptide vaccines and generic peptides

The company’s multiple sites offer an unprecedented long-term security of supply and an exclusive focus on pharmaceutical peptide manufacturing.

PolyPeptide Group manufactures more than a third of all approved peptide drug substances, which accounts for more than 25% of sales of outsourced peptide therapeutics manufacturing worldwide.

The company’s knowledge and experience can help clients with an orphan drug with limited regulatory requirements, a therapeutic with a requirement for large quantities or a peptide vaccine encountering specific challenges.

Well-known peptides such as calcitonin, desmopressin, leuprolide and octreotide are in PolyPeptide Group’s portfolio. New generic peptides in the portfolio include eptifibatide, bivalirudin, exenatide and lanreotide.

Support for all regulatory and approval processes is provided, as well as full GMP documentation for all generic products, where applicable. Thus includes US Drug Master Files and certificates of suitability.

Organic chemistry services

Complementary services for peptide development include:

  • A comprehensive catalogue of more than 1,250 bioactive peptides, from the simplest to the most complex molecules
  • Custom synthesis of research-grade peptides, stable and radio isotope-labelled peptides, lead optimisation, pre-GMP and process development for future scale-up, including bulk non-GMP manufacturing
  • Simple to complex peptides, including peptides conjugated to polyethylene glycol (PEG) and other compounds.

The company’s catalogue includes more than 700 special amino acids and derivatives, building blocks and turn mimics, all available from inventory.

Custom organic chemicals can be developed in-house. Custom synthesis of non-peptidic molecules, from several grams to several hundreds of grams and cGMP manufacturing at the kilogram scale can also be provided.

About PolyPeptide Group

PolyPeptide Group is one of the world’s largest independent contract manufacturers of therapeutic peptides for the pharmaceutical market, which employs more than 450 people in six manufacturing sites worldwide.

With an exclusive focus on peptides and an established track record with the FDA, as well as other regulatory agencies, the company offers manufacturing services of peptide pharmaceuticals.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

Quality by Design: A Peptide CMO Approach

Implementation of Quality by Design (QbD) is a challenge as well as a necessity in order to be successful in a business where competition is increasing and timelines are ever more challenging. This paper shortly describes the ideas and principles we are working according to in order to shorten de

Address
PolyPeptide Laboratories San Diego

9395 Cabot Drive

San Diego

92126

California

United States of America

+1 858 408 0808 +1 858 408 0799 www.polypeptide.com

PolyPeptide Group Images

Products and Services

Video

White Papers

Press Release

4 January 2017

The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l'Alleud has been completed.

Read more
8 December 2016

Lonza and the PolyPeptide Group have jointly announced that PolyPeptide Laboratories Holding (PPL) has entered into a definitive agreement with Lonza Sales and Lonza to acquire its peptides business and operations in Braine-l'Alleud, Belgium.

Read more
7 September 2010

Implementation of Quality by Design (QbD) is a challenge as well as a necessity in order to be successful in a business where competition is increasing and timelines are ever more challenging. This paper shortly describes the ideas and principles we are working according to in order to shorten de

Read more

Regional Offices

PolyPeptide Group

PolyPeptide Laboratories France SAS

7 rue de Boulogne

67100 Strasbourg

Other

France

+33 3 88 79 08 79 +33 3 88 79 18 56 www.polypeptide.com
PolyPeptide Laboratories A/S

Herredsvejen 2

3400 Hillerød

Other

Denmark

+45 4820 7000 +45 4820 7005 www.polypeptide.com
PolyPeptide Laboratories, Inc.

365 Maple Avenue

CA

Torrance

90503

Other

United States of America

+1 310 782 3569 +1 310 782 3645 www.polypeptide.com
PolyPeptide Laboratories San Diego

9395 Cabot Drive

San Diego

92126

California

United States of America

+1 858 408 0808 +1 858 408 0799 www.polypeptide.com

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.